Vancomycin and clarithromycin show synergy against Mycobacterium abscessus in vitro

• Main Authors: Mukherjee, D, Wu, M.-L, Teo, J.W.P, Dick, T
• Other Authors: PHARMACY
• Format: Article
• Published: American Society for Microbiology 2020
• Subjects: clarithromycin; vancomycin; tuberculostatic agent; antibacterial activity; Article; bacterial growth; bacterium isolate; controlled study; drug effect; drug potentiation; fractional inhibitory concentration index; gene mutation; in vitro study; minimum inhibitory concentration; Mycobacterium abscessus; Mycobacterium massiliense; nonhuman; nucleotide sequence; priority journal; type strain; atypical mycobacteriosis; combination drug therapy; human; lung disease; microbial sensitivity test; microbiology; treatment outcome; Antibiotics, Antitubercular; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Humans; Lung Diseases; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Treatment Outcome; Vancomycin
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/175145
• Institution: National University of Singapore

10.1128/AAC.01298-17